Tesamorelin + CJC-1295 + Ipamorelin
Also known as: Tesa / CJC / Ipa blend, GH-axis triple stack, Tri-GH blend
Pre-mixed three-peptide blend aimed at stimulating the growth-hormone axis, combining two GHRH analogs (tesamorelin and CJC-1295) with a selective ghrelin-receptor agonist / GH secretagogue (ipamorelin) to drive pulsatile pituitary GH release. Tesamorelin is FDA-approved only as Egrifta for HIV-associated lipodystrophy; CJC-1295 and ipamorelin have no FDA-approved human indication and are grey-market research compounds. This specific three-way combination is not an approved product and has no published controlled human efficacy or safety data, so its rationale is inferred from the individual components rather than from any trial of the blend itself.
Common research uses
Pricing for Tesamorelin + CJC-1295 + Ipamorelin
Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.
No sellers for Tesamorelin + CJC-1295 + Ipamorelin are indexed yet — we add vendors and their prices as we find them.
COAs for Tesamorelin + CJC-1295 + Ipamorelin
2 third-party tests across 1 vendor. Each card links to the full report.
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.